Calpain-1, also called mu-calpain or μ-calpain, is a calcium-dependent cysteine protease that cleaves cytoskeletal and signaling proteins.
Athens Bioscience supplies human calpain-1 purified from erythrocytes, frozen at ≥95% purity by SDS-PAGE. It is used in proteolysis and substrate cleavage studies, calpain inhibitor screening, and neurodegeneration and muscle research. Porcine calpain-1 is also available.
Calpain-1 (μ-Calpain) is a calcium-dependent cysteine protease composed of an 80 kDa catalytic subunit (CAPN1) and a 30 kDa regulatory subunit (CAPNS1), forming a heterodimer stabilized by domain interactions. The catalytic subunit contains four domains: domain II harbors the protease active site, while domain IV binds calcium, enabling activation at micromolar concentrations (EC₅₀ ≈ 50 μM). The regulatory subunit’s domain VI facilitates membrane association and modulates calcium sensitivity. Calpain-1 regulates cellular processes including cytoskeletal remodeling, signal transduction, and synaptic plasticity by cleaving substrates like protein kinase C (PKC), focal adhesion kinase, and β-spectrin, often altering their activity or localization.
Dysregulated calpain-1 activity is implicated in neurodegenerative diseases such as Alzheimer’s, where excessive cleavage of tau and amyloid precursor protein exacerbates neurofibrillary tangle formation. In cardiovascular pathologies, calpain-1 promotes vascular smooth muscle calcification via matrix metalloproteinase-2 activation and transforming growth factor-β1 signaling, contributing to atherosclerosis. Renal proximal tubule injury involves calpain-1-mediated degradation of cytoskeletal proteins (paxillin, talin), leading to cell necrosis. Conversely, calpain-1 activation during long-term potentiation (LTP) supports synaptic plasticity and neuroprotection by degrading inhibitors of ERK signaling, such as PHLPP1β.
Therapeutically, calpain-1-specific inhibitors (e.g., peptidyl α-ketoamides) are under investigation for traumatic brain injury and ischemia, aiming to mitigate calcium-induced proteolysis. Recombinant calpain-1 expression systems enable structural studies to refine drug design. Additionally, calpain-1 activity serves as a biomarker for disease progression in Alzheimer’s and cardiovascular disorders, with elevated levels correlating with tissue damage. These dual roles-as a mediator of physiological plasticity and pathological degradation-underscore its potential as a therapeutic target across diverse conditions.
Common uses include proteolytic enzyme studies, neurological and cardiac injury research, metabolic and calcium homeostasis studies.
New size available. Please see the Product Change Notice.
None
None
None - not classified as hazardous
12 - Non Combustible Liquids
Not applicable - not a hazardous mixture. Standard laboratory hygiene practices recommended.
Calpain-1, also called mu-calpain or μ-calpain, is a calcium-dependent cysteine protease that cleaves cytoskeletal and signaling proteins.
Athens Bioscience supplies human calpain-1 purified from erythrocytes, frozen at ≥95% purity by SDS-PAGE. It is used in proteolysis and substrate cleavage studies, calpain inhibitor screening, and neurodegeneration and muscle research. Porcine calpain-1 is also available.